GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abliva AB (OSTO:ABLI) » Definitions » Price-to-Operating-Cash-Flow

Abliva AB (OSTO:ABLI) Price-to-Operating-Cash-Flow : (As of Jun. 10, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Abliva AB Price-to-Operating-Cash-Flow?

As of today (2024-06-10), Abliva AB's share price is kr0.174. Abliva AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.03. Hence, Abliva AB's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Abliva AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Abliva AB's highest Price-to-Operating-Cash-Flow Ratio was 226.71. The lowest was 0.00. And the median was 171.80.

OSTO:ABLI's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 25.02
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Abliva AB's Cash Flow from Operations per share for the three months ended in Mar. 2024 was kr-0.03. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.03.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 70.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 51.60% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 30.10% per year.

During the past 13 years, Abliva AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 70.10% per year. The lowest was -159.80% per year. And the median was -3.15% per year.


Abliva AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Abliva AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abliva AB Price-to-Operating-Cash-Flow Chart

Abliva AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Abliva AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Abliva AB's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Abliva AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abliva AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abliva AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Abliva AB's Price-to-Operating-Cash-Flow falls into.



Abliva AB Price-to-Operating-Cash-Flow Calculation

Abliva AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.174/-0.026
=

Abliva AB's Share Price of today is kr0.174.
Abliva AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Abliva AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Abliva AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Abliva AB (OSTO:ABLI) Business Description

Industry
Traded in Other Exchanges
Address
Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Abliva AB is a Swedish company that is active in pharmaceutical development. It develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare, and often very severe diseases occur when the cell's energy provider, the mitochondria, does not function properly. The portfolio includes projects at different stages and ranges from the early discovery phase to the clinical phase.

Abliva AB (OSTO:ABLI) Headlines

No Headlines